<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02364856</url>
  </required_header>
  <id_info>
    <org_study_id>2013_22</org_study_id>
    <secondary_id>2014-A00583-44</secondary_id>
    <nct_id>NCT02364856</nct_id>
  </id_info>
  <brief_title>Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis.</brief_title>
  <official_title>Assessment of Pain Through Parasympathetic Tone Analysis : Applicability in Children With Cerebral Palsy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Investigation Centre for Innovative Technology Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondation Motrice</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates Analgesia Nociception Index (Heart Rate Variability based index) and its
      variations after painful stimulations in children with cerebral palsy : acute procedural pain
      (botulinum toxin injections), and recurrent pain (physiotherapy).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cerebral Palsy (CP) is the most common cause of motor handicap in childhood. CP is caused by
      damage to the developing brain, resulting in limits in movement, posture, or communication
      ability. CP affects about one newborn on 450. Pain management is one of the major
      expectations of CP patients (La Foundation Motrice, 2009) but in this population, pain is not
      recognized and inadequately treated.

      Autonomic nervous system (ANS) is the automatic part of our nervous system regulating vital
      functions like cardiac beats or respiration. It is divided in sympathetic and
      parasympathetic. Analysis of heart rate variability (HRV) allows isolation of variations due
      to parasympathetic and their study. Works from the CIC-IT 807 lead to creation of an index
      called ANI (Analgesia Nociception Index), which is very sensitive to pain. It is validated on
      adults (Jeanne, 2012). It could be helpful to assess pain in CP, particularly in patients
      with communication disabilities. It is important to study this new tool in CP children before
      developing clinical applications.

      Main objective of this study is to demonstrate that ANI is relevant in CP children and that
      it is sensitive to pain like in adults. Population will be 40 CP children (6-18y) receiving
      rehabilitation therapy in specialized centres. Duration of the study is 2 years. Parent's
      consent should be obtained. Investigators will record heart rate of children in 3 conditions
      in their rehabilitation centres: usual position, acute procedural pain (botulinum toxin
      injections), and recurrent pain (physiotherapy). Parameters will be calculated in CIC-IT 807
      lab (heart rate, ANI). Values of ANI and heart rate before and after painful stimulations
      will be compared. Correlation between ANI and results of usual pain assessment tools (rFLACC
      scale, visual analog scale) or characteristics of the population will be analyzed.

      Lille University Hospital and CIC-IT 807 lab will collaborate with 2 pediatric rehabilitation
      centers: Centre Marc Sautelet and Zuydcoote Hospital.

      Expected result is that ANI is relevant to CP children. Clinical applications are multiple:
      pain assessment, adaptation of medical equipment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 24, 2015</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesia Nociception Index ANI before and after painful stimulation</measure>
    <time_frame>300 seconds before and 300 seconds after painful stimulation</time_frame>
    <description>ANI is calculated from heart rate recordings 300 seconds before and after painful stimulations and compared</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ANI at baseline</measure>
    <time_frame>300 seconds at rest</time_frame>
    <description>ANI calculated from Heart rate recordings during 300 seconds in patient's usual position</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time for recovering</measure>
    <time_frame>10 minutes after painful stimulation</time_frame>
    <description>time for recovering baseline ANI after painful stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score measured by Visual Analog Scale</measure>
    <time_frame>immediately after painful stimulation</time_frame>
    <description>when VAS will be applicable, children will be asked to score their pain with VAS scale; results of pain ratings with VAS will be compared to ANI results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score measured by rFLACC scale</measure>
    <time_frame>immediately after painful stimulation</time_frame>
    <description>rFLACC scale will be scored immediately after painful stimulation; results of pain ratings with rFLACC will be compared to ANI results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dysautonomic symptoms</measure>
    <time_frame>inclusion</time_frame>
    <description>results of ANI measures will be compared between two groups according to presence or absence of dysautonomic symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gross Motor Function Classification System</measure>
    <time_frame>inclusion</time_frame>
    <description>results of ANI measures will be compared to the severity of motor impairment through the Gross Motor Function Classification System</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cerebral Palsy</condition>
  <condition>Pain</condition>
  <condition>Children</condition>
  <arm_group>
    <arm_group_label>Children with cerebral palsy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Analgesia Nociception Index</intervention_name>
    <description>The Analgesia Nociception Index (ANI, MDoloris Medical Systems, Lille, France), based on Heart Rate Variability analysis, measures continuously and non-invasively the influence of Respiratory Sinus Arrhythmia on the heart rate. This 0-100 index indicates the proportion of paraS over sympathetic activity. In adults during surgery under general anesthesia, ANI decreases after painful stimulation and has been related to the balance between analgesia and nociception.
ANI is calculated from heart rate recording.</description>
    <arm_group_label>Children with cerebral palsy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Our population will be 40 CP children (6-18y) receiving rehabilitation therapy in
        specialized centres.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cerebral Palsy

          -  Rehabilitation care with physiotherapy and/or toxinum botulinum injections

          -  Absence of identified autonomic nervous system disease

          -  Parental and children (if applicable) consent obtained

          -  French National Health System cover

        Exclusion Criteria:

          -  baseline Respiratory Frequency &gt; 30/min

          -  beta-blockers or atropinic treatment

          -  Pacemaker, cardiac rhythm disease

          -  Diabetes mellitus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justine AVEZ-COUTURIER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Justine AVEZ-COUTURIER, MD</last_name>
    <email>justine.couturier-avez@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Lille, Pôle Enfant, Hôpital Roger Salengro</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justine AVEZ-COUTURIER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Justine AVEZ-COUTURIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de Réadaptation Fonctionnelle Marc Sautelet</name>
      <address>
        <city>Villeneuve-d'Ascq</city>
        <zip>59650</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ISABELLE HEYMANN, MD</last_name>
      <phone>03 28 80 07 70</phone>
      <email>isabelle.heymann@marcsautelet.com</email>
    </contact>
    <investigator>
      <last_name>ISABELLE HEYMANN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>AMELIE HAMAIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>ANNE YATZIMIRSKY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>CLOTILDE DEBARBIEUX, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital maritime de Zuydcoote, Service de SSR Enfant</name>
      <address>
        <city>Zuydcoote</city>
        <zip>59123</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ANNE SCHILL, MD</last_name>
      <phone>03 28 26 22 85</phone>
      <email>a.schill@ch-zuydcoote.fr</email>
    </contact>
    <investigator>
      <last_name>ANNE SCHILL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>MARIE CELINE GELLEZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Jeanne M, Delecroix M, De Jonckheere J, Keribedj A, Logier R, Tavernier B. Variations of the analgesia nociception index during propofol anesthesia for total knee replacement. Clin J Pain. 2014 Dec;30(12):1084-8. doi: 10.1097/AJP.0000000000000083.</citation>
    <PMID>24525906</PMID>
  </reference>
  <reference>
    <citation>Jeanne M, Clément C, De Jonckheere J, Logier R, Tavernier B. Variations of the analgesia nociception index during general anaesthesia for laparoscopic abdominal surgery. J Clin Monit Comput. 2012 Aug;26(4):289-94. doi: 10.1007/s10877-012-9354-0. Epub 2012 Mar 28.</citation>
    <PMID>22454275</PMID>
  </reference>
  <reference>
    <citation>De Jonckheere J, Rakza T, Logier R, Jeanne M, Jounwaz R, Storme L. Heart rate variability analysis for newborn infants prolonged pain assessment. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:7747-50. doi: 10.1109/IEMBS.2011.6091909.</citation>
    <PMID>22256134</PMID>
  </reference>
  <reference>
    <citation>Faye PM, De Jonckheere J, Logier R, Kuissi E, Jeanne M, Rakza T, Storme L. Newborn infant pain assessment using heart rate variability analysis. Clin J Pain. 2010 Nov-Dec;26(9):777-82.</citation>
    <PMID>20973153</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2015</study_first_submitted>
  <study_first_submitted_qc>February 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2015</study_first_posted>
  <last_update_submitted>June 6, 2017</last_update_submitted>
  <last_update_submitted_qc>June 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autonomic Nervous System</keyword>
  <keyword>Cerebral Palsy</keyword>
  <keyword>Pain</keyword>
  <keyword>Children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

